| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President And CEO
1 company
McCarthy Sean A. is a CEO at CytomX Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 13,052 | $21.04 | $274,614.08 | -73.8% | |
| Dec 1, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 14,340 | $20.60 | $295,404.00 | -75.5% | |
| Nov 1, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 14,342 | $19.86 | $284,832.12 | -77.2% | |
| Oct 4, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 19,120 | $24.13 | $461,365.60 | -81.8% | |
| Oct 2, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 9,562 | $18.57 | $177,566.34 | -69.3% | |
| Sep 1, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 9,930 | $17.32 | $171,987.60 | -70.1% | |
| Aug 31, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 18,756 | $17.50 | $328,260.00 | -62.0% | |
| Aug 9, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 4,781 | $15.00 | $71,715.00 | -53.0% | |
| Jul 3, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 4,781 | $15.52 | $74,201.12 | -53.0% | |
| Jun 26, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 4,481 | $15.00 | $67,215.00 | -51.4% |